StockData
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc. (FULC) stock

FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.75+0.04 (+1.08%)

Close on Nov 17, 2026Market cap $286.12MP/E –Yield –

Fulcrum Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Fulcrum Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 0.6× to 4.5×, with a median of 1.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−2.2
2025Dec 31, 20253.1×+2.1
2024Dec 31, 20241.0×−0.4
2023Dec 29, 20231.4×−0.3
2022Dec 30, 20221.7×−1.4
2021Dec 31, 20213.1×+0.1
2020Dec 31, 20203.0×−0.6
2019Dec 31, 20193.7×–

More Fulcrum Therapeutics figures

See a number that looks wrong?